LEMAITRE VASCULAR INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lemaitre Vascular Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q3 2024.
  • Lemaitre Vascular Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.61M, a 22.6% increase year-over-year.
  • Lemaitre Vascular Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.23M, a 35.5% increase year-over-year.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.32M, a 27.5% increase from 2022.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2022 was $4.17M, a 19.9% increase from 2021.
  • Lemaitre Vascular Inc annual Share-based Payment Arrangement, Expense for 2021 was $3.48M, a 15.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.23M $1.61M +$297K +22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $5.94M $1.61M +$297K +22.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.64M $1.61M +$320K +24.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $5.32M $1.4M +$720K +105% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.6M $1.31M +$127K +10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $4.47M $1.31M +$176K +15.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.3M $1.29M +$123K +10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $4.17M $684K -$202K -22.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.38M $1.19M +$389K +48.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.99M $1.14M +$267K +30.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.72M $1.17M +$240K +25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.48M $886K +$133K +17.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $3.35M $797K +$110K +16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $3.24M $869K +$66K +8.22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $3.17M $927K +$148K +19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.02M $753K +$206K +37.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $2.82M $687K +$32K +4.89% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.78M $803K +$109K +15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.68M $779K +$33K +4.42% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.64M $547K -$8K -1.44% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $2.65M $655K +$118K +22% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $2.53M $694K +$58K +9.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.47M $746K +$125K +20.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $2.35M $555K +$145K +35.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $2.2M $537K -$350K -39.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.55M $636K +$164K +34.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $2.39M $621K +$134K +27.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $2.26M $410K -$75K -15.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $2.33M $887K +$354K +66.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $1.98M $472K +$140K +42.2% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $1.84M $487K +$157K +47.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $1.68M $485K +$149K +44.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-11
Q3 2016 $1.53M $533K +$54K +11.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $1.48M $332K +$51K +18.1% Apr 5, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $1.43M $330K +$2K +0.61% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1.42M $336K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $479K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $281K Apr 4, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $328K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.